Skip To Main Content
Stacey L. Clardy on Muck Rack

Stacey L. Clardy

Utah
As seen in: American Academy of Neurology, Neurology Minute, JAMA Network, Neurology
MD PhD Autoimmune Neurologist. Assoc. Prof @UofUNeurology. Section Editor, Neurology Podcast @GreenJournal & Neurology Minute @AANmember.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Stacey L.

Contact Stacey L., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease

|
By Andreu Vilaseca, Philippe A. Bilodeau, Georgios Gakis, Andrea Savransky, Linda Nguyen, Sam I. Hooshmand, Sammita Satyanarayan, Carson E. Moseley, Chantal Roy-Hewitson, Mariano Marrodan, Haiwen Chen, Yoji Hoshina, Edgar Carnero Contentti, Lorna Galleguillos, Margaret Upchurch, Caitlin Jackson-Tarlton, Joanne Guo, Michelle Fabian, Akash Virupakshaiah, Georgina Arrambide, Emmanuelle Waubant, Laura Boschetti, Jorge Correale, Andres Villa, Brenda Banwell, Romain Marignier, Sean J. Pittock, Benjamin M. Greenberg, Jeffrey Bennett, Tracey A. Cho, Stacey L. Clardy, Andrew Solomon, Ilya Kister, Scott S. Zamvil, Jeffrey M. Gelfand, Pavle Repovic, Ahmed Z. Obeidat, Kyle Blackburn, Silvia N. Tenembaum, John Chen, Elias S. Sotirchos, Michael Levy, Eoin P. Flanagan, Fabián Hernández Murillo, Laura Cacciaguerra, Mulan Jiang, Dean M. Wingerchuk, Leah Haley, Adriana Casallas, Analisa Manin, Aniela Grzezulkowska, César Caparó-Zamalloa, Rafael Paterno, Stephanie B. Syc-Mazurzek, Susan E. Horsman
| JAMA Network Verified
Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease Key Points Question Do observational data suggest interleukin-6 receptor blockers (IL-6RB) may be an effective and safe therapy for relapse prevention in myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD)?
Open in Who Shared Issue with article?

A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial

|
By Ka-Ho Wong, Stacey L. Clardy, Gregory Scott, Hyun Joo Sophie
| Neurology Verified
Study Protocol Open Accesspodcast Related Podcast Introduction Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is a life-threatening, antibody-mediated autoimmune disorder of the central nervous system.
Open in Who Shared Issue with article?

Ted M. Burns, MD, FAAN (1966-2022)

|
By Stacey L. Clardy, Andrew M. Southerland, Robert Gross
| Neurology Verified
REQUIREMENTS If you are uploading a letter concerning an article: You must have updated your disclosures within six months: http://submit.neurology.org Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
Open in Who Shared View Duplicates (20) Issue with article?
See all 5 articles